Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

NEUPHORIA THERAPEUTICS INC (NEUP)

17 + Investors. Track Smart Money conviction in NEUP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
50%

Smart Money Signals — NEUP

Based on 17 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their NEUP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 81% of 2.2Y peak

81% of all-time peak
17 funds currently hold this stock — 81% of the 2.2-year high of 21 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +143% more funds vs a year ago

fund count last 6Q
+10 new funds entered over the past year (+143% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 50% buying

9 buying9 selling
Last quarter: 9 funds bought or added vs 9 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~4 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 2 → 9 → 9 → 4. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 65% entered in last year

6% conviction (2yr+) 29% medium 65% new
Only 1 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
➡️

Steady discovery — ~4 new funds/quarter

3 → 2 → 9 → 9 → 4 new funds/Q
New funds entering each quarter: 2 → 9 → 9 → 4. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 71% of holders entered in last year

6% veterans 24% 1-2yr 71% new
Of 17 current holders: 12 (71%) entered in the past year, only 1 (6%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 5% AUM from top-100

5% from top-100 AUM funds
5 of 17 holders rank in the top 100 by AUM, but together hold only 5% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.3
out of 10
Moderate Exit Risk
Exit risk score 5.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NEUP

In 2026 Q1, 9 hedge funds were net buyers of NEUP (4 opened a new position, 5 added to an existing one), while 9 reduced or exited (1 trimmed, 8 sold completely) — a 50% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 17.

Hedge Fund Ownership: NEUP

How many hedge funds hold NEUP — quarterly history vs. share price
Quarterly hedge fund ownership of NEUP vs. share price

Market Analysis: NEUP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NEUP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy NEUPHORIA THERAPEUTICS INC (NEUP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NEUP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 51d ago
NEUP
+24.1%
XLV
+0.4%

NEUP outperformed XLV by +23.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 6d ago
NEUP
+4.2%
XLV
+1.4%

Since the filing became public, NEUP outperformed XLV by +2.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

2 top-rated funds 0 high-conviction
Consensus
2.1
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: NEUP
17 + Investors

Track Smart Money conviction in NEUP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 17 21 -19.05%
13F Shares 2M 1M 10.9%
Total Value $6M $6M 13.59%
New Positions 4 9 -5
Increased Positions 5 9 -4
Closed Positions 8 3 +5
Reduced Positions 1 1 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: NEUP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

17 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NEUP. Verified SEC 13F-HR filings.

QUARTER:
Top 16 institutional holders of NEUP — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lynx1 Capital Management LP 0.56% 875,328 $3.6M
2 AdvisorShares Investments LLC 0.12% 155,367 $632K
3 Squadron Capital Management LLC 0.11% 76,728 $312K
4 Shay Capital LLC 0.05% 151,010 $615K
5 FNY Investment Advisers, LLC 0.05% 26,500
6 Ikarian Capital, LLC 0.02% 47,443 $193K
7 Merck & Co., Inc. 0.01% 10,027 $41K
8 ADAR1 Capital Management, LLC 0.01% 30,000 $122K
9 Virtu Financial LLC 0.00% 12,033
10 BALYASNY ASSET MANAGEMENT L.P. 0.00% 142,183 $579K
11 BOOTHBAY FUND MANAGEMENT, LLC 0.00% 14,000 $57K
12 COMMONWEALTH EQUITY SERVICES, LLC 0.00% 11,222 $46K
13 CITADEL ADVISORS LLC 0.00% 19,331 $79K
14 UBS Group AG 0.00% 2,316 $9K
15 RHUMBLINE ADVISERS 0.00% 202
16 MORGAN STANLEY 0.00% 58
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — NEUPHORIA THERAPEUTICS INC (NEUP)

What does the Smart Money Trend signal show for NEUP?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their NEUP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for NEUP?

Slight buying edge — 50% buying: Last quarter: 9 funds bought or added vs 9 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NEUP holders?

Smaller funds dominant — 5% AUM from top-100: 5 of 17 holders rank in the top 100 by AUM, but together hold only 5% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held NEUP?

Mostly new holders — 65% entered in last year: Only 1 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy NEUPHORIA THERAPEUTICS INC (NEUP) following the 2026 Q1 hedge fund 13F filings?

As of today, NEUP has moved +4.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of +2.8%. Since the quarter end (March 31, 2026), NEUP has gained +24.1% vs +0.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →